In The News

Kwok Daniel Now Taking Risperdal Cases

15 Jul

Posted by Christine in In The News, Uncategorized

Risperdal Lawsuit and Settlement With Government

Last year, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the manufactures of Risperdal and Invega, entered into a $2.2 billion settlement with the U.S. Department of Justice for over promoting the drugs. The $2.2 billion settlement was paid to the U.S. Treasury. No monies were paid to patients.

Risperdal and Invega were approved to treat persons with schizophrenia. The government alleged that J&J and Janssen promoted the drugs for unapproved uses, including children with mental disabilities or other mental conditions.

Furthermore, the government alleged that J&J and Janssen knew Risperdal triggered the production in boys of prolactin, a hormone that stimulates breast development and milk production.

Despite this knowledge, as explained by the Department of Justice, one of Janssen’s Key Base Business Goals was to grow and protect the drug’s market share with child/adolescent patients. Janssen instructed its sales representatives to call on child psychiatrists, as well as mental health facilities that primarily treated children, and to market Risperdal as safe and effective for symptoms of various childhood disorders, such as attention deficit hyperactivity disorder, oppositional defiant disorder, obsessive-compulsive disorder and autism. Until late 2006, Risperdal was not approved for use in children for any purpose, and the FDA repeatedly warned the company against promoting it for use in children.

Invega was approved only for the treatment of schizophrenia and schizoaffective disorder. Yet, J&J and Janssen also allegedly marketed the drug for off-label indications and made false and misleading statements about its safety.

Legal Rights of Risperdal Patients who Developed Enlarged Breasts

Manufacturers of prescription drugs have a duty to patients to produce safe products and to warn patients — and their parents if the patients are children — and their doctors of any adverse health effects.

If your child was prescribed Risperdal or Invega and was subsequently diagnosed with gynecomastia, you may be eligible to file a lawsuit against J&J and Janssen seeking damages for his suffering, mental anguish, and physical impairment, as well as past and future medical expenses. Adults prescribed Risperdal either as children or as young adults may also be able to file direct personal injury lawsuits against J&J and Janssen.

Contact Board Certified Trial Attorney Rob Kwok

We will provide a free, no obligation, and confidential review of your case. Please contact Rob Kwok to discuss your potential Risperdal gynecomastia lawsuit by clicking on the form link – here.
Or call us toll-free at 1-866-466-KWOK and ask to speak to trial attorney Rob Kwok.

Risperdal and Invega are trademarks owned by Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, and used for product identification purposes only. Rob Kwok nor anyone from Kwok Daniel Ltd LLP are affiliated with these companies. This website has not been endorsed or approved by Johnson & Johnson and Janssen Pharmaceuticals.